Comparison of therapies in lumbar degenerative disc disease: a network meta-analysis of randomized controlled trials.

CONCLUSION: activL substantially improves ODI success, back pain, and patient satisfaction compared with other therapies for single-level lumbar DDD. PMID: 29542364 [PubMed - in process]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research